Please login to the form below

Not currently logged in
Email:
Password:

Spirit Health Group offers new market access consultancy service

Spirit Access will support the pharmaceutical and device industries

offering

Following the acquisition of a majority stake in patient pathway and healthcare development company Pathway Communications, Spirit Healthcare Group has launched a new offering in the form of a market access consultancy service.

Spirit Access will combine Pathway Communications’ knowledge of the pharmaceutical and medical technology market with Spirit Healthcare’s resources and expertise in delivering healthcare services to the NHS.

The new venture will provide data analysis, simulation, modelling, implementation and digital solutions to its pharmaceutical and NHS clients.

Chris Barker, chief executive officer of Spirit Health Group, said: “Spirit Access’ aim is to use our digital technology, implementation services and pathway experience to work with pharmaceutical and medical technology companies to add value for the NHS, industry and most importantly patients.”

More specifically, Pathway Communications, which has developed a number of patient pathway simulations for a range of disease areas, will be delivered to NHS customers through Spirit’s implementation model.

Heading up the new offering as managing director, David Southern, former managing director of Pathway Communications, said: “We have worked closely with Spirit over a number of years and there is a strong synergy between the companies that, combined, becomes stronger than two halves.

“Spirit has an extensive background in working with the NHS organisations, but has a range of products that offer complementary ways for the NHS to unlock further value from pharmaceutical and medical device products.

“Likewise, Pathway Communications has a strong track record of working with pharma and wanted to forge a relationship with an organisation which could deliver an implementation model to help the NHS achieve the much needed cost savings and patient benefit outcomes.”

Article by
Gemma Jones

20th April 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you in the world of the patient...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics